NETCast

In this episode of NETCAST, neuroendocrine experts Dr. Mosalem and Dr. Wahl meet with Taymeyah Al-Toubah discuss the latest advancements in neuroendocrine tumor treatments, focusing on peptide receptor radionuclide therapy (PRRT) with alpha and beta emitters. They delve into the safety and efficacy of new investigational agents, the challenges of hematological toxicity, and the imp

In this podcast episode, neuroendocrine experts Dr. Liu and Dr. Gujarathi meet with Dr. Phan to discuss the latest advancements in neuroendocrine tumor research, focusing on innovative models for studying G1 and G2 neuroendocrine tumors, the implications of genetic mutations in pancreatic neuroendocrine tumors, and the future of drug screening and treatment protocols. The conversat

In this episode of NETCAST, leading neuroendocrine experts Dr. Mohammed and Dr. Chauhan meet with Dr. Gangi to discuss their recent studies on innovative therapies for neuroendocrine tumors. Dr. Chauhan presents findings on Peltocetine, a new oral somatostatin receptor agonist, highlighting its efficacy in treating carcinoid syndrome. Dr. Mohammed shares insights on NP101, a combin

In this episode of NETCast, Dr. Jason Starr engages with patient advocacy leaders in the NET community to review highlights and insights from the 2024 NANETS Annual Symposium. Lisa Yen, Jessica Thomas, and Josh Mailman discuss the evolving role of patients in their care, the need for more therapies for neuroendocrine carcinoma, and the significance of building trust between patient

In this episode, Dr. Aman Chauhan joins Dr. Renuka Iyer to discuss the critical updates in neuroendocrine tumors, focusing on the AJCC staging system and its implications for clinical practice. The conversation covers the evolution of staging systems, the role of biomarkers like chromogranin A, the importance of endoscopists in management, and the outcomes for appendiceal neuroendo

DLL3 approval in eSCLC and how it can be used in extrapulmonary PDNEC/small cell. Dr. Phan speaks with Dr. Jain about treatment options for neuroendocrine carcinoma. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

NET Regional Education Conference Jointly Provided by The University of Minnesota and The Mayo Clinic. Dr. Lou and Dr. Halfdanarson spoke with Dr. Phan and Dr. Chandrasekharan about Systemic Therapy for NETs Beyond SSAs (Including Sequencing) and Well-differentiated G3 NETs. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#

Join us for Episode 24 of NETCast. Mayo Clinical Gastrointestinal Oncologist Dr. Jason Starr interviews Lisa Yen from LACNETS and Stephanie Alband from INCA and The PheoPara Alliance, patient advocacy groups that partner with NANETS. Join us as we discuss ways we are Bridging the Gap for patient advocacy. See Privacy Policy at https://art19.com/privacy and California Privacy Notic

Join us for Episode 23 of NETCast. Ohio State University Medical Oncology Specialist Dr. Vineeth Sukrithan interviews Dr. Simron Singh professor of medicine at the University of Toronto and co-founder of the Susan Leslie Clinic for Neuroendocrine Tumors. He is also a medical oncologist and affiliate scientist in the Odette Cancer Research Program at Sunnybrook Research Institute. J

Join us for Episode 22 of NETCast. Mayo Clinical Gastrointestinal Oncologist Dr. Jason Starr interviews Hematologist & Oncologist Dr. Bassam Sonbol about bone marrow toxicity associated with PRRT. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.